Paper20007533
Peptide-MHC class II complex stability governs CD4 T cell clonal selection.
Baumgartner CK and 4 others. J Immunol, 2010. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Peptide-MHC class II complex stability governs CD4 T cell clonal selection. Papers, record 20007533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20007533
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4-Positive T-Lymphocytes | Major topic |
| Histocompatibility Antigens Class II | Major topic |
| Peptides | Major topic |
| Animals | |
| Autoimmunity | |
| Clone Cells | |
| Half-Life | |
| Immunization | |
| Mice | |
| Mutation | |
| Protein Stability |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| J 2851 | Austrian Science Fund FWF | Austria | PubMed | |
| U19 A162627 | PHS HHS | United States | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,449,771 | An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10449771 | PubMed |
| 2 | 10,229,191 | A kinetic basis for T cell receptor repertoire selection during an immune response. | Immunity | 1999 | https://conductscience.org/library/papers/10229191 | PubMed |
| 3 | 12,459,592 | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | Science | 2002 | https://conductscience.org/library/papers/12459592 | PubMed |
| 4 | 11,956,295 | Structural basis of cytochrome c presentation by IE(k). | J Exp Med | 2002 | https://conductscience.org/library/papers/11956295 | PubMed |
| 5 | 11,904,393 | Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/11904393 | PubMed |
| 6 | 11,801,666 | C-terminal anchoring of a peptide to class II MHC via the P10 residue is compatible with a peptide bulge. | J Immunol | 2002 | https://conductscience.org/library/papers/11801666 | PubMed |
| 7 | 16,039,577 | The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. | Immunity | 2005 | https://conductscience.org/library/papers/16039577 | PubMed |
| 8 | 11,207,290 | Structural and functional consequences of altering a peptide MHC anchor residue. | J Immunol | 2001 | https://conductscience.org/library/papers/11207290 | PubMed |
| 9 | 9,143,690 | Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. | Annu Rev Immunol | 1997 | https://conductscience.org/library/papers/9143690 | PubMed |
| 10 | 17,881,563 | Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17881563 | PubMed |
| 11 | 3,012,351 | Correlations between T-cell specificity and the structure of the antigen receptor. | Nature | 1986 | https://conductscience.org/library/papers/3012351 | PubMed |
| 12 | 15,100,274 | The magnitude of TCR engagement is a critical predictor of T cell anergy or activation. | J Immunol | 2004 | https://conductscience.org/library/papers/15100274 | PubMed |
| 13 | 14,690,592 | Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. | Mol Cell | 2003 | https://conductscience.org/library/papers/14690592 | PubMed |
| 14 | 11,163,193 | Selective activation and expansion of high-affinity CD4+ T cells in resistant mice upon infection with Leishmania major. | Immunity | 2000 | https://conductscience.org/library/papers/11163193 | PubMed |
| 15 | 9,655,481 | Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. | Immunity | 1998 | https://conductscience.org/library/papers/9655481 | PubMed |
| 16 | 8,145,819 | Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. | Nature | 1994 | https://conductscience.org/library/papers/8145819 | PubMed |
| 17 | 17,627,303 | A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17627303 | PubMed |
| 18 | 11,120,826 | Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response. | J Immunol | 2000 | https://conductscience.org/library/papers/11120826 | PubMed |
| 19 | 7,535,476 | Antigen-specific development of primary and memory T cells in vivo. | Science | 1995 | https://conductscience.org/library/papers/7535476 | PubMed |
| 20 | 18,251,991 | Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. | Immunology | 2008 | https://conductscience.org/library/papers/18251991 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,657,027 | Phosphorylation shapes antigen presentation and immune recognition: mechanistic insights and translational perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42657027 | PubMed |
| 42,589,216 | Structural Remodeling of TCR-HLA-DQ8 Recognition by a β-Cell Stress-Associated C19S Insulin Neoepitope in Type 1 Diabetes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589216 | PubMed |
| 42,278,376 | Structural Modulation and Binding of HLA-DQ8 by Cysteine-to-Serine Mutated Insulin Peptide: Insights from Molecular Dynamics Simulations. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278376 | PubMed |
| 39,475,096 | PRR adjuvants restrain high stability peptides presentation on APCs. | Elife | 2024 | https://conductscience.org/library/papers/39475096 | PubMed |
| 39,136,115 | How do adjuvants enhance immune responses? | Elife | 2024 | https://conductscience.org/library/papers/39136115 | PubMed |
| 38,250,071 | H2-O deficiency promotes regulatory T cell differentiation and CD4 T cell hyperactivity. | Front Immunol | 2023 | https://conductscience.org/library/papers/38250071 | PubMed |
| 38,102,157 | An immunoinformatics study reveals a new BoLA-DR-restricted CD4+ T cell epitopes on the Gag protein of bovine leukemia virus. | Sci Rep | 2023 | https://conductscience.org/library/papers/38102157 | PubMed |
| 34,997,058 | High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD). | Sci Rep | 2022 | https://conductscience.org/library/papers/34997058 | PubMed |
| 34,433,672 | PD-1 preferentially inhibits the activation of low-affinity T cells. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34433672 | PubMed |
| 34,266,882 | Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/34266882 | PubMed |
| 34,026,437 | Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT-II T Cell Activation Conferring Tumor Protection in Mice. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34026437 | PubMed |
| 30,778,242 | Quantifying in situ adaptive immune cell cognate interactions in humans. | Nat Immunol | 2019 | https://conductscience.org/library/papers/30778242 | PubMed |
| 30,379,846 | Amino acid signatures in the HLA class II peptide-binding region associated with protection/susceptibility to the severe West Nile Virus disease. | PLoS One | 2018 | https://conductscience.org/library/papers/30379846 | PubMed |
| 30,349,037 | LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII. | Nat Immunol | 2018 | https://conductscience.org/library/papers/30349037 | PubMed |
| 26,906,089 | Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes. | J Immunol Methods | 2016 | https://conductscience.org/library/papers/26906089 | PubMed |
| 26,870,289 | Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine model. | Oncol Lett | 2016 | https://conductscience.org/library/papers/26870289 | PubMed |
| 26,779,136 | Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study. | Front Microbiol | 2015 | https://conductscience.org/library/papers/26779136 | PubMed |
| 25,485,681 | Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA. | J Clin Invest | 2015 | https://conductscience.org/library/papers/25485681 | PubMed |
| 25,086,170 | Antigen signal strength during priming determines effector CD4 T cell function and antigen sensitivity during influenza virus challenge. | J Immunol | 2014 | https://conductscience.org/library/papers/25086170 | PubMed |
| 24,167,504 | The control of the specificity of CD4 T cell responses: thresholds, breakpoints, and ceilings. | Front Immunol | 2013 | https://conductscience.org/library/papers/24167504 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20007533
GET https://conductscience.org/api/papers/v1/20007533/references?page=2